Adasuve Aerosol, Powder
Product Images NDC 51097-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Adasuve (NDC 51097-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alexza Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Adasuve 02)
Figure 3 (Adasuve 03)
Figure 4 (Adasuve 04)
Figure 5 (Adasuve 05)
Figure 6 (Adasuve 06)
Figure 7 (Adasuve 07)
Chemical Structure (Adasuve 08)
Figure 8 (Adasuve 09)
This appears to be a graph or table showing the Mean Plasma Loxapine Concentration and Wean Plasma Loxapine Concentration over time after dosing (in minutes) for the medication ADASUVE 10mg in a study with 8 participants. Without additional context, the purpose or significance of the data cannot be determined.*
Figure 9 (Adasuve 10)
Figure 10 (Adasuve 11)
Adasuve-12 (Adasuve 12)
ADASUVE is a medication that should only be administered through oral inhalation, and it is not recommended for patients with symptoms of respiratory problems or those taking medications to treat these problems. This medication is provided in a single-use packaging, and it should be discarded after use. The manufacturer is Alexza Pharmaceuticals. For more detailed information, refer to the package insert. The medication should be stored between 15°C-30°C (59°F-86°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.